Tumutod, Zelina Feoana .
HRN: 23-35-42 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/20/2023
CEFUROXIME 500MG (TAB)
07/20/2023
07/27/2023
PO
500mg
BID X 7 Days
UTI
Waiting Final Action
Indication: Empirical De-escalation Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes